CD274 and head and neck squamous cell carcinoma: PD-L1 expression in TCs at different cut-off points, measured using the VENTANA PD-L1 (SP263) Assay, was reported to not be prognostic for OS in patients with HNSCC who received standard-of-care chemotherapies (26).